News & AnalysisSamsara Biocapital targets $500m for fundSamsara Biocapital is seeking to raise $500 million for its new fund, according to an SEC filing.ByIris Dorbian4 January 2021•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.FundraisingFundraisingHealthcareBriefs